Navigation Links
International Council on Nanotechnology launches global research needs assessment
Date:4/16/2008

WASHINGTON - As nanotechnology has moved out of the laboratory and into commercial products, many have begun to question the impact of nanoscale materials on health and the environment. Learning more about such impacts, however, presents a daunting task, given the number of potential products, the pace of innovation, and the need to share information and leverage costs toward a more efficient, timely international research effort. A major challenge has been to produce a global research strategy for predicting the interactions between engineered nanoparticles and biological systems so that biocompatible nanomaterials can be developed and applied safely.

Last year, more than 70 experts from 13 countries in academia, industry, governments and non-governmental agencies accepted that challenge. In an unprecedented international collaboration, the International Council on Nanotechnology (ICON) convened two workshops aimed at defining a set of research needs for assessing potential nanotechnology impacts.

The results of this multi-stakeholder effort, funded by ICON and the National Science Foundation, will be unveiled on Thursday, May 1, when ICON, in partnership with the Project on Emerging Nanotechnologies, releases the International Assessment of Nanotechnology Environment, Health and Safety Research Needs a report on the findings of the two workshops.

Confirmed speakers include Professor Vicki Colvin, Executive Director of ICON; Dr. Sally Tinkle, Science Advisor to the Acting Director, NIEHS/NIH; Dr. Michael Thompson, Business Development Manager-Nanotechnology, FEI Company; Dr. Richard Denison, Senior Scientist, Environmental Defense Fund; and Dr. Andrew Maynard, Chief Science Advisor to the Project on Emerging Nanotechnologies.

This program will take place on Thursday, May 1, 2008, in the 6th Floor Board Room of the Woodrow Wilson International Center for Scholars in Washington, DC.

*** Webcast LIVE at '/>"/>

Contact: Colin Finan
colin.finan@wilsoncenter.org
202-691-4321
Project on Emerging Nanotechnologies
Source:Eurekalert

1

GOOD

Page: 1 2

Related biology technology :

1. IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference
2. Cryo-Cell International, Inc. Reports First Quarter 2008 Results
3. Genetic Engineering and Biotechnology News (GEN) Blog: International Students in the United States - A Diminishing Pool of Talent for Biotech?
4. Sangui BioTech International, Inc., Reports Sales Increase, Continued Losses
5. China YCT International Group, Inc. Announces Entrusted Management Agreement With Its Primary Supplier
6. International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM) Initiative
7. Quest International Announces They Will be First in US to Exhibit True 12-Bit Grayscale Mammographic Images
8. VWR International, LLC Acquires Jencons (Scientific) Ltd, UK
9. MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer
10. Aridol(TM) Endorsed by International Olympic Committee
11. BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading ... that it will be launching the Human MicroRNA ... using its SmartChip(TM) Real-Time PCR System. The ... microRNA panel of 885 microRNAs on a single ... the use of its proprietary SmartChip Real-Time PCR ...
(Date:12/16/2009)... Resources, one of the world,s leading research and ... that, according to responses from surveyed dermatologists, Centocor ... inhibitors) will capture 22 percent of the biologics ... moderate to severe psoriasis. Among these two agents, ... times as much patient share as briakinumab. ...
(Date:12/16/2009)... -- Eppendorf has initiated an,import ban for ... for,infringement of European patent EP 1 179 ... the quantification of a target compound". The ... the respective products into any country of,the ... confiscate any,violating products. , ...
(Date:12/15/2009)... -- Repligen Corporation (Nasdaq: RGEN ) today ... research funding to support the ongoing development of ... Dystrophy Association (MDA). This grant will support ... GMP manufacture of a drug candidate for human ... only provides important funding for Repligen,s research but ...
Breaking Biology Technology:WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 4In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3
... Human Genome,Sciences, Inc. (Nasdaq: HGSI ) ... to the HGS Board of Directors. He will ... Committee. Until recently, Mr. Southwell was,at Sepracor, Inc., ... Vice President and Chief Financial Officer, and also ...
... by an Additional ... $44.5 million, SEATTLE, July ... single institutional investor,has agreed to purchase, for $44.5 million, newly issued 18.33% ... and a,warrant to purchase approximately 28.2 million shares of common stock with,an ...
... to standard mixes of lubricants and refrigerants could ... for factories, hospitals, ships, and others with large ... Institute of Standards and Technology (NIST) research that ... varying concentrations of nanoparticle additives indicate a major ...
Other Biology Technology:Human Genome Sciences Appoints David P. Southwell to its Board of Directors 2Human Genome Sciences Appoints David P. Southwell to its Board of Directors 3Human Genome Sciences Appoints David P. Southwell to its Board of Directors 4Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants 2Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants 3Cool! Nanoparticle research points to energy savings 2
(Date:12/16/2009)... cells, molecules form an intricate network of interactions. ... measure individual molecular reactions outside the cells. Since ... in the laboratory, scientists suspect that the kinetics ... from external probes. We expected the cellular reaction ... Dieter Braun. "However, our novel optical approach showed ...
(Date:12/16/2009)... School of Medicine researcher will lead the coordinating center ... in the field of stem cell research. Michael L. ... chosen by the National Heart, Lung and Blood Institute ... national experts, which will be called the NHLBI Progenitor ... by a $30 million grant over seven years. ...
(Date:12/16/2009)... BIO-key International, Inc. (OTC Bulletin Board: BKYI), ... finger-based biometric identification solutions, announced that a ... Shareholder Meeting held today approved the sale ... Interact911 Mobile Systems Inc. Of the shares ... 1.2% were opposed. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ...
Breaking Biology News(10 mins):Looking for the heartbeat of cellular networks 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 1DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 2DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 3Partnership for Prescription Assistance Prepared to Help Midwestern Workers Hurt by Recession 59220 1Partnership for Prescription Assistance Prepared to Help Midwestern Workers Hurt by Recession 59220 2Partnership for Prescription Assistance Prepared to Help Midwestern Workers Hurt by Recession 59220 3Partnership for Prescription Assistance Prepared to Help Midwestern Workers Hurt by Recession 59220 4Costa Atlantica Receives a Perfect Score for Vessel Sanitation 59215 1Costa Atlantica Receives a Perfect Score for Vessel Sanitation 59215 2Costa Atlantica Receives a Perfect Score for Vessel Sanitation 59215 3
... study from the forthcoming issue of The American Naturalist ... of females in many diving beetle populations. Their findings ... arises when the costs and benefits of multiple matings ... male versus female arms race (involving physical structures, behaviors, ...
... under laboratory circumstances prion-protein can be absorbed across the gut, ... real life. In addition, the results show that the places ... are different from the locations where infectivity is known to ... of Pathology. , Since the outbreak of BSE in cattle ...
... be available in the near future, results of a ... how such contraception is reversible within a few months. ... vasectomy) are not acceptable to many couples because they ... In a similar way to ovulation suppression by hormone ...
Other Biology News:New evidence questions the simple link between prion proteins and madcow disease 2New evidence questions the simple link between prion proteins and madcow disease 3Hormonal male contraception reversible after few months for all men 2
... Inhibitor (patent pending) is a protein based ... and inhibits the most common and troublesome ... and T1. SUPERaseIn can be used in ... problematic. It is ideal for in vitro ...
... Ribonuclease Inhibitor is a potent ... such as RNase A. Like ... Ribonuclease Inhibitor is an acidic ... ~52 kDa. RNaseOUT inhibits RNase ...
...
... Core Kit contains all the ... assays on a wide range ... to dNTPs, the Core Kit ... used BIOLASE DNA polymerase, which ...
Biology Products: